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Abstract
We propose a molecular generative model based on the conditional variational
autoencoder for de novo molecular design. It is specialized to control multiple
molecular properties simultaneously by imposing them on a latent space. As a
proof of concept, we demonstrate that it can be used to generate drug-like
molecules with five target properties. We were also able to adjust a single
property without changing the others and to manipulate it beyond the range of
the dataset.
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Introduction
The ultimate goal of molecular design for new materials and drugs is to directly
generate molecules with the desired properties. This is apparently challenging work
because a molecular space is extraordinarily vast, discrete, and disorganized with
diverse types of molecules. For instance, 108 molecules have been synthesized,[1]
whereas it is estimated that there are 1023 to 1060 drug-like molecules.[2] Despite
advances in experimental techniques, it is too demanding to find molecules suitable
for specific applications only through experiments.
Computer-aided molecular design has attracted much attention as a promising so-
lution to overcome the experimental limitation.[3, 4, 5, 6] Fast calculation methods
along with reasonable accuracy and very low cost enable high-throughput virtual
screening to find molecules with target properties. A common strategy is to se-
lect computationally top molecules out of millions of molecules in a virtual library
and then verify them experimentally, leading to a significant reduction in time and
efforts. Molecules in the library may not meet the given criteria. In this case, tra-
ditional optimization methods such as a genetic algorithm can be used to further
improve molecular properties beyond the criteria by structural modifications.[7, 8, 9]
However, they have a fundamental limitation in terms of efficiency because many
trials and errors are inevitable to optimize molecular properties in a huge molecular
space.
Recently emerging generative models based on deep learning techniques may of-
fer a viable solution for more efficient molecular design. Go´mez-Bombarelli et al.
adopted a variational autoencoder[10] to optimize the molecular properties in a la-
tent space in which molecules are expressed as a real vector.[11] The key advantage
of this method is that a gradient-based optimization becomes feasible because the
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latent space is continuous and differentiable. It has been successfully applied to
improving the partition coefficient of drug candidates and the delayed fluorescent
emission rate of organic light emitting diode candidates. Blaschke et al. employed
the adversarial autoencoder[12] (AAE) and the Bayesian optimization to generate
ligands specific to the dopamine type 2 receptor.[13] Kadurin et al. compared the
VAE and AAE as a molecular generation model in terms of the reconstruction er-
ror and variability of the output molecular fingerprints.[14] In addition to those
autoencoder-based models, a generative model developed for natural language pro-
cessing has also been used for molecular design.[15, 16, 17, 18] Molecular structures
can be expressed with SMILES. Then, this model learns the probability distribution
of the next character of a given piece of SMILES. Yuan et al. designed potential
inhibitors for a target protein and tested them in experiments.[16] Based on the
natural language processing model, Segler et al. and Gupta et al. applied transfer
learning to molecular design for certain biological activities.[17, 18] This approach
is especially useful when there is not enough data to train artificial neural net-
works in the normal way. Olivecrona et al., Guimaraes et al., and Jaques et al.
proposed a reinforcement learning method to modify a pre-trained molecular gen-
erative model so as to impose several properties in molecules generated from the
generative model.[19, 20, 21]
We note that various molecular properties are correlated with each other. There-
fore, adjusting one target property by structural modifications may cause an unde-
sired change in other properties. To avoid this problem in rational molecular design,
one has to control several properties at the same time. Here, we propose a molecular
generative model using the conditional variational autoencoder (CVAE)[22] suitable
for multivariable control. In addition to the advantages of using the latent space,
our method can incorporate the information of molecular properties in the encoding
process and manipulate them in the decoding process.
As a proof of concept, we used the CVAE to generate drug-like molecules satisfying
five target properties at the same time: molecular weight (MW), partition coefficient
(LogP), number of hydrogen bond donor (HBD), number of hydrogen acceptor
(HBA), and topological polar surface area (TPSA). We were able to produce a
number of molecules with the specific values of the five target properties within
a given range. It was also possible to adjust a single target without changing the
others. Furthermore, we were able to generate molecules with properties beyond the
range of the database.
Method
Conditional variational autoencoder (CVAE)
We selected the CVAE as a molecular generator. It is one of the most popular
generative models which generates objects similar to but not identical to a given
dataset. In particular, it is distinguished from the VAE in that it can impose cer-
tain conditions in the encoding and decoding processes. To elucidate the difference
between the two models, we compared their objective functions with one another.
The objective function of the VAE is given by
E[logP (X|z)]−DKL[Q(z|X) ‖ P (z)],
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where E denotes an expectation value, P and Q are probability distributions, DKL
is the Kullback-Leibler divergence, and X and z indicate the data and latent spaces,
respectively. The first and second terms are also called the reconstruction error and
the KL term, respectively. In an autoencoder, Q(z|X) and P (X|z) are approximated
by an encoder and a decoder, respectively. A key difference of the CVAE from the
VAE is to embed the conditional information in the objective function of the VAE,
leading to the revised objective function as follow:
E[logP (X|z, c)]−DKL[Q(z|X, c) ‖ P (z|c)],
where c denotes a condition vector. The condition vector c is directly involved in
the encoding and decoding processes. In our model, the molecular properties we
want to control were represented as the condition vector. As a result, the CVAE
can generate molecules with the target properties imposed by the condition vector.
Incorporating molecular properties in the VAE to generate molecules with de-
sirable properties are also possible through a two-step model proposed by Go´mez-
Bombarelli et al. The VAE is trained jointly with an additional neural network
for property prediction. Subsequently, a Gaussian process model creates a mapping
from the resulting latent space to the associated molecular properties Finally, prop-
erty optimization in the resulting latent space is performed by a gradient descent
optimization method.
The key difference of our CVAE model from the jointly trained VAE model is
that the molecular properties are directly incorporated into both the encoder and
decoder. The resulting latent vector is composed of two parts: the first part is
for the target molecular properties, while the second part involves the molecular
structures and the other properties. Therefore, the desired molecular properties can
be embedded in a target molecular structure simply by setting a condition vector. In
other words, one can control the structure and the properties independently except
for some cases in which the properties are strongly coupled to a molecular scaffold.
This is particularly useful to incorporate a certain property in a given molecule
just with a marginal structure modification. After all, the CVAE is less sensitive
to the continuity and smoothness of the latent space, because it does not require
the derivative of the latent space with respect to the latent vector of the molecular
structure. Another technical difference of the CVAE from the jointly trained VAE
is that it does not need any further optimization process, which is inevitable in the
jointly trained VAE for each different property value.
Molecular representation and model construction
We represented molecules with SMILES codes to take advantage of state-of-the-art
deep learning techniques that are specialized in dealing with texts and sequences.
Each SMILES code was canonicalized for a unique molecular representation. One
’E’ was padded on the end of the SMILES code to indicate the end of the string.
Subsequently, each character including ’E’ is represented with a one-hot vector, re-
sulting in an input matrix. Each one-hot vector of the input matrix is transformed
to an embedding vector with the size of 300, and then the input matrix is concate-
nated with a predefined condition vector. The first, second, and last entries of the
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condition vector are filled with information consisting of the MW, LogP, and TPSA,
respectively, while the remaining two entries are labeled by the HBD and HBA as
shown in Figure 1. The values of MW, logP, and TPSA are normalized from -1.0 to
1.0. HBD and HBA are expressed with a one-hot vector, because they are integer
numbers.
The resulting matrix is subjected to the encoder of the CVAE to generate a latent
vector. We adopted the so-called recurrent neural network (RNN) with an LSTM
cell for both the encoder and decoder of the CVAE.[23] They were made of a 3-
layer RNN with 500 hidden nodes on each layer. A softmax layer was used in each
output of the decoder cell, and a cross entropy was used as the cost function of
the reconstruction error. The latent vector concatenated with the condition vector
becomes an input of the decoder at each time step of the RNN cell. Finally, the
output vector of each decoder cell is transformed to a vector whose size is equal
to that of the one-hot vector of the input matrix. The softmax activation function
is applied to each transformed vector. The encoder and decoder are optimized to
minimize the cost function of the CVAE. To generate a molecule with the target
properties imposed by the condition vector, the cell of the RNN decoder was un-
rolled for 120 times. All characters before ‘E’ were taken in the stochastic write-out
process, and if ‘E’ did not appear in the 120 characters, the result was considered as
invalid. Each output vector of the decoder cell represents the probability distribu-
tion of the SMILES code characters and ’E’. Finally, the output vector is converted
to a SMILES code. It should be noted that even a single wrong character in the
resulting SMILES code gives rise to an invalid molecule. To increase the rate of
valid SMILES codes, we used the stochastic write-out method which samples each
character of SMILES according to a probability distribution. As a result, a single
set of latent and condition vectors may give a number of different molecules. We
performed 100 times the stochastic write-out per one latent vector and took all valid
molecules except duplicated ones for later analysis.
Dataset and hyperparameters
RDKit[24], an open source cheminformatics package, was used for checking out the
validity of the generated SMILES codes and calculating the five target properties
of the molecules.
The total dataset is made of molecules randomly selected from the ZINC
dataset.[25] Generally, with more data, the performance becomes better. Typical
deep learning models need hundreds of thousands of data points. We checked out the
convergence of the results with respect to the size of the data in our case. The use of
5,000,000 ZINC molecules did not increase both the validation and the success rates
of generating molecules with the target properties compared to those from 500,000
ZINC molecules. Thus, we adopted the dataset of the 500,000 molecules, 80 % of
which were used for training, and the rest was used for the test. The distribution
of the five target properties in the total dataset is shown in Figure 2. The learning
rate was set to 0.0001 and exponentially decayed at a rate of 0.97. The model was
trained until converged. In the performance evaluation of the CVAE, if each target
property of the generated molecules was different from the given target value with
the 10 % error range of the average value of the total dataset, we regarded those
molecules as successful.
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Figure 1 Schematic representation of conditional variational autoencoder for molecular design
Figure 2 Distribution of molecular weight, LogP, HBD, HBA, and TPSA in the total dataset
(500,000).
Result
As the first application, we demonstrated that the CVAE method can generate
molecules with specific values for the five target properties by applying it to Aspirin
and Tamiflu. The values of the (MW, LogP, HBD, HBA, and TPSA) for Aspirin
and Tamiflu are (180.04, 1.31, 1, 3, and 63.6) and (312.2, 1.285, 2, 5, and 90.64),
respectively. The condition vector of each molecule was made by those values. Latent
vectors to be concatenated with the condition vector were sampled by adding a
Gaussian type noise to the latent vector of a molecule selected randomly in the
training set. Figures 3A and 3B show nine molecules produced with the condition
vector of Aspirin and Tamiflu, respectively. All of them had similar properties to
those of Aspirin and Tamiflu within an error range of 10%, respectively. However,
the molecular structures in Figure 3 are considerably different from those of the
original molecules because of the latent vectors chosen randomly from the training
set.
The second application was to generate molecules similar in both properties and
structure to the mother molecule by sampling latent vectors around that of the
mother. Figure 4 shows the molecules generated in such a way from Aspirin. They
look very similar to Aspirin and also have similar properties with those of Aspirin
within an error range of 10 %.
As the third case study, we tested whether the CVAE method can change only a
single property without changing the others. The condition vector was constructed
with the MW, HBD, HBA, and TPSA of Tamiflu, and we varied LogP from 0.0
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Figure 3 Molecules generated by the CVAE with the condition vector made of the five target
properties of (A) Aspirin and (B) Tamiflu.
Figure 4 Molecules generated by the CVAE with the condition vector made of the five target
properties of Aspirin and the latent vector slightly modified from that of Aspirin.
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to 3.0. Latent vectors were sampled around that of Tamiflu. Figure 5 shows the
result. All the molecules have similar properties to the original ones except LogP
as desired. The molecules from the top left to the bottom right have gradually
increasing LogP values from -0.23 to 3.55. In some cases, however, such a delicate
control of individual properties was not possible. For instance, we could not generate
molecules with a LogP beyond 4.0. It is probably because LogP is not completly
independent from the other four properties, so a substantial change in LogP entails
a change in the others. Moreover, it was difficult to adjust the MW and TPSA
independently because the MW and TPSA are highly correlated with one another.
Finally, we investigated the possibility to change a specific molecular property
beyond the range of a training set. Latent vectors were sampled around molecules
in the training set. In the condition vector, the five properties were given randomly
except for a single target property. The target property was set to 10 % larger than
its maximum value in the training set (e.g., 5.5 for LogP and 165.5 for TPSA).
Figure 6 shows the resulting molecules. Indeed, it was able to generate molecules
with a LogP larger than 5.5 (Figure 6A) and molecules with a TPSA larger than
165.5 (Figure 6B). We compared the distribution of the LogP and TPSA for 1,000
randomly selected molecules from the training set and 1,000 generated molecules
with property values outside of the range of the dataset (toward larger values).
Figure7 shows that the distribution of the target properties are shifted to larger
values, leading to an increased ratio of molecules with property values outside of
Figure 5 Molecules generated by the CVAE with the condition vector made of MW, HBD, HBA,
and TPSA of Tamiflu and continuously changing LogP.
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the range. The rate of valid molecules is relatively low compared to the case of
generating molecules with property values in the range of the dataset.
Figure 6 (A) Molecules with LogP larger than 5.5. (B) Molecules with TPSA larger than 165.
Figure 7 Distribution of A) LogP and B) TPSA for 1000 randomly selected molecules in training
set and 1000 generated molecules with LogP and TPSA outside of the range of the dataset,
respectively.
We analyzed the latent space constructed by the CVAE. Two principle axes were
extracted by principal component analysis. Figure 8 shows the two components of
the latent vectors of 1000 randomly selected molecules from the test set with their
LogP and TPSA values. Molecules with similar properties are likely located around
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Table 1 Numbers of attempts and valid molecules for generating 100 molecules whose five properties
are the same with those of Aspirin, Tamiflu, Lenalidomide, Rivaroxaban, and Pregabalin.
condition random
attempts
molecules
valid
number of
%)
(100/attempts,
success rate
attempts
molecules
valid
number of
%)
(100/attempts,
success rate
Aspirin 28,840 32,567 0.34 758,199 711,660 0.014
Tamiflu 15,960 34,696 0.62 798,183 741,960 0.013
Lenalidomide 502,00 89,230 0.19 865,695 822,060 0.012
Rivaroxaban 92,620 47,574 0.11 866,205 817,800 0.012
Pregabalin 77,680 84,371 0.13 782,010 723,360 0.014
a same region of the latent space in the jointly-trained VAE. In our CVAE model,
the latent vector is comprised of two parts as explained in the method section.
Therefore, a specific region in the latent space does not necessarily have a correlation
with the target molecular properties which are controlled by the condition vector.
This is good because the separation of information enables a more flexible control
of the molecular structure and properties when generating new molecules.
Figure 8 The latent space of 1000 randomly selected molecules with MW, LogP and TPSA
values.
Apart from the successful applications of the CVAE method, it has a drawback
that should be resolved. The success rate of generating desirable molecules is very
low. We tested how many attempts are required to generate 100 molecules with
the five desired properties and how many valid molecules are generated during
those attempts. We also compared when the condition vector is set randomly or to
target properties to show the effect of the condition vector for generating desirable
molecules.
Table 1 summarizes the number of attempts for generating 100 molecules whose
five properties are same as those of aspirin, Tamiflu, Lenalidomide, Rivaroxaban,
and Pregabalin, respectively. Lenalidomide, Rivaroxaban, and Pregabalin are top
selling small molecule drugs in 2016.[26] In Table 1, ’condition’ means that the con-
dition vector was set as the five properties of the target molecules, whereas ’random’
means that the condition vector was randomly made. The number of valid molecules
in Table 1 indicates the number of valid molecules generated during the attempts
to create molecules with the five desired properties. For example, 100 aspirin-like
molecules and 32,567 valid moleculces were obtained from 28,840 attempts to create
aspirin-like molecules. The reason why the number of valid molecules is larger than
the number of attempts is that the stochastic write-out process is performed 100
times for each attempt. All successful molecules (100 per each target molecule) are
reported in the Supporting Information. It should be noted that the success rate
dramatically dropped when the condition vector is randomly set. It clearly mani-
fests that the successful molecules generated by the CVAE in the example studies
were not the result of many random trials.
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Table 2 Number of generation attempts and number of valid molecules for three different sampling
methods of latent vectors. The generation process was continued until 100 molecules with the five
target properties were successfully created from a single target molecule, and it was repeated for 100
target molecules selected randomly from the ZINC dataset. The table shows the average values over
the 100 target molecules.
sampling method
valid molecules
average number of
attempts
average number of
(100/attempts, %)
success rate
around target molecules 67640.5 199340.1 0.05
around known molecules 31799.4 21659.9 0.46
random 50316.4 78888.2 0.12
We further analyzed the performance of the CVAE by investigating the change in
the success rate and the number of valid molecules according to latent vector sam-
pling methods. We employed three different sampling methods: random, around the
latent vectors of known molecules, and around the latent vectors of target molecules.
For all the sampling methods, the condition vector was constructed using the five
properties of the target molecules. The generation process was continued until 100
molecules with the five target properties were successfully created from a single
target molecule, and it was repeated for 100 target molecules selected randomly
from the ZINC dataset. Table 2 shows the average values for the success rate and
the number of valid molecules over the 100 target molecules. It was unexpected
that sampling latent vectors around a target molecule was the most ineffective in
terms of the success rate and valid molecules because of the high rate of duplicated
molecules. In this case, the structure of the generated molecules was very similar to
that of the target molecule shown in Figure 4. Sampling latent vectors around those
of known molecules performed best. Because the known molecules were randomly
selected from the ZINC set, their structures and properties would be considerably
different from those of a target molecule. Nonetheless, we were able to generate
molecules with the desired properties from those latent vectors with a relatively
high success rate. It manifests that the condition vector appropriately modified the
molecular structures to have the target properties. Finally, it was also possible to
generate desirable molecules from completely random latent vectors but with a low
success rate.
We suspect that at some part the overall low success rates regardless of the la-
tent vector sampling methods are due to the strong correlation between the five
target properties. In addition, it is known that the discrete nature of SMILES
causes a high rate of invalid molecules in the decoding process from latent vec-
tors to molecules.[27] The stochastic write-out method circumvents this problem,
but more fundamental solutions should be devised. More severely, SMILES does
not have the 3D conformational information of molecular structures. Therefore, it
must have limitations in applications in which conformational effects are critical.
Molecular graph representation incorporating conformational information can be
a promising alternative. Encoding molecular graphs seems to be straightforward,
but decoding from a latent space to molecular graphs is still an open problem. Re-
cently, significant progress along this line has been made.[28, 29, 30] Such a better
molecular representation may also improve the success rate of molecular generation.
We expect that the success rate may be further improved by using the grammar
variational autoencoder[27] and the reinforcement learning.[19, 20]
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Conclusion
We proposed a new molecular design strategy based on the conditional variational
autoencoder. Instead of high-throughput virtual screening, our method as one of the
deep learning-based generative models directly produces molecules with desirable
target properties. In particular, its strength is controlling multiple target properties
simultaneously by imposing them on a condition vector. We demonstrated that it
was possible to generate drug-like molecules with specific values for the five target
properties (MW, LogP, HBD, HBA, and TPSA) within an error range of 10%.
In addition, we were able to selectively control LogP without changing the other
properties and to increase a specific property beyond the range of the training set.
Thus, this new method has attractive applicability for efficient molecular design.
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